Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : WaveRider WAVC NASDAQ ISP Wide Area Wireless Internet -- Ignore unavailable to you. Want to Upgrade?

To: Chisy who wrote (1431)	2/19/2000 5:44:00 PM
From: mapstock	Read Replies (1) \| Respond to of 1848

I don't know but he likes wavc and he's picked alot of winners in the past and he has a following. Check it out about halfway down geocities.com

To: Chisy who wrote (1431)	2/20/2000 3:44:00 PM
From: kinetic	Read Replies (1) \| Respond to of 1848

From Kiplinger's July 1999 LAMB AMONG THE LIONS How I'll Be an Investment Guru By William Giese All I need are a few great ideas. Got any? Hip and savvy as always, I've been wondering: What's next for stocks, now that the Dow is firmly over 10,000 and Internet stocks are hinting at wear and tear? You see, I want to be an Internet guru -- one of those people who are looked upon as men and women of stature and substance, worthy of respect. (Meeting me in person, people would ask, "Are you the real William Giese?" I'd smile modestly and reply, "Just call me Bill.") Anyway, my plan is to be arbiter of what's next. Right now, I'm hoping that biotech stocks are next. See more highlights from the July issue of Kiplinger's Personal Finance Magazine. Subscribe here The Giese portfolio of five stocks includes four bargain-priced biotechs. The most expensive is Geron, a company engaged in chromosome research. Its shares cost me roughly the same as lunch for two at McDonald's. Cheaper yet are two biotech holdings with prices on par with a large Starbucks cappuccino and a medium latte, respectively. My humblest biotech costs less than a roll of Necco wafers. These biotech stocks are cheap because the underlying companies lose money. (I read somewhere that only 5% of all publicly traded biotechs are profitable.) Still, Geron just bought the rights to the technology that produced Dolly the cloned sheep, so you never know. DOES RICEEN KNOW? Lately I've been rooting for biotech stocks on a popular Internet investor bulletin board, finance.yahoo.com. It was there, under the topic Geron, that I first heard about the mysterious Riceen, who publishes weekly stock predictions on a Web page and who correctly predicted a two-point Geron rise. In addition to Geron, Riceen made a sharp call with CustomTracks, an Internet company. A while back, Riceen forecast upward moves by 11 stocks. Eight of them went up the following week. (Of course, other predictions have gone wrong, but maybe it's just a matter of timing.) I imagine Riceen to be intense and slightly unsettling -- a Wharton MBA grad in her late twenties, perhaps. Irresistibly curious, I track down Riceen, who turns out to be a guy named Marty. He's 57 and in the auto-parts business on Long Island. He's married with twin granddaughters. Marty wanted to name his Web page after his son, Richard, but that name was taken, as were all near variations except Riceen. Marty says he gets stock tips from cable channels, such as CNBC, and he relies strongly on his intuition. "I am not poor," he explains over the phone. "In my portfolio I keep your Sprints and your Citigroups, basically your blue chips, and don't sell them. But with 20% of my portfolio, I take a gamble." The Riceen stocks are the 20 percenters, of course, but hold on: Is this one of those deals where he buys a stock, inflates the price with happy predictions and then sells? Marty insists that's not the case. He buys only a few hundred shares of each of these stocks. So why the Riceen stuff? "I like the idea of everyone trying to figure out who Riceen is," replies Marty. "Is it a she? Is she from China? I'm sort of a mystery." I can see that: He's Mr. Buy 'n Hold except when lightning financial moves are required and then he becomes. . . Riceen! But hold on again: What if people start to believe in Riceen? What if good folks invest money they can't afford to lose on Riceen's say-so? Wouldn't he feel obligated to do serious analysis before publishing? "I'm trying to keep this a fun-type thing," Marty answers somewhat stiffly. HELP ME OUT. As I said, I am anxious to become a stock guru, too, but I confess I don't know what's next. Maybe you do. If you have a great What's Next stock tip, send details, including research leads, to billgiese@yahoo.com and I'll take it from there. Look for me on the Internet, under the name Dolly.